Neurogenic pulmonary edema (NPE) is an acute life-threatening complication following an injury of the spinal cord or brain, which is associated with sympathetic hyperactivity. The role of nitric oxide (NO) in NPE development in rats subjected to balloon compression of the spinal cord has not yet been examined. We therefore pretreated Wistar rats with the NO synthase inhibitor N G -nitro-L-arginine (L-NAME) either acutely (just before the injury) or chronically (for 4 weeks prior to the injury). Acute (but not chronic) L-NAME administration enhanced NPE severity in rats anesthetized with 1.5 % isoflurane, leading to the death of 83% of the animals within 10 min after injury. Pretreatment with either the ganglionic blocker pentolinium (to reduce blood pressure rise) or the muscarinic receptor blocker atropine (to lessen heart rate decrease) prevented or attenuated NPE development in these rats. We did not observe any therapeutic effects of atropine administered two minutes after spinal cord compression. Our data indicate that NPE development is dependent upon a marked decrease of heart rate under the conditions of high blood pressure elicited by the activation of the sympathetic nervous system. These hemodynamic alterations are especially pronounced in rats subjected to acute NO synthase inhibition. In conclusion, nitric oxide has a partial protective effect on NPE development because it attenuates sympathetic vasoconstriction and consequent baroreflex-induced bradycardia following spinal cord injury.
INTRODUCTION
Neurogenic pulmonary edema (NPE) is an acute life-threatening complication following spinal cord or brain injury (4) . It is characterized by marked pulmonary vascular congestion, extravasation of protein-rich edema fluid and intraalveolar hemorrhage (7) (8) (9) (10) . Many pathophysiological mechanisms have been implicated in the development of neurogenic pulmonary edema, but the exact cascade leading to its development is still unclear (9, 10) .
Both the release of vasoactive substances and a severe transient sympathetic discharge are thought to participate in this process (23, 24) . These processes lead to an increase in pulmonary capillary hydrostatic pressure, damage to the alveolar wall and the leakage of fluid into the intraalveolar space (4).
Our previous experiments showed that severe neurogenic pulmonary edema could be experimentally induced by rapid epidural balloon compression of the thoracic spinal cord in rats anesthetized by 1.5% isoflurane in air (18, 19) . Moreover, particular procedures preventing the rapid activation of the sympathetic nervous system, such as ganglionic blockade by pentolinium, slow gradual inflation of the balloon or transection of the spinal cord at the same level instead of spinal compression, prevented the development of neurogenic pulmonary edema (18, 22) .
Nitric oxide is generated from L-arginine by the enzyme nitric oxide syntase (NOS). Some data suggest that NO may play an important role during the development of NPE. Intravenous administration of L-arginine has been reported to prevent increased pulmonary capillary permeability in high-altitude pulmonary edema (1) . Neurogenic pulmonary edema, which is also characterized by elevated pulmonary vascular permeability, may be inhibited by NO produced in the medulla oblongata (5, 8) . In the nucleus tractus solitarii of the medulla oblongata as well as in the rostroventrolateral medulla, there are blood pressure (BP) controlling regulatory centers that are also called "NPE trigger zones". The injection of NOS inhibitors into the close proximity of these centers or into the cerebrospinal fluid enhances sympathetic tone (6, 27) , probably by the modulation of the arterial baroreflex (6, 13) . On the basis of our previous experiments (20) (21) (22) , we have proposed a hypothesis that NPE develops in rats in which a pronounced decrease of heart rate (HR) is elicited by a baroreflex activated by the early BP rise following a massive catecholamine discharge from the sympathetic nervous system. The aim of this study was i) to evaluate the role of NO in the development of NPE following balloon compression of the thoracic spinal cord, and ii) to test the above hypothesis of the importance of baroreflex-induced cardiac deceleration (occurring shortly after spinal cord compression) for further NPE development. To achieve this goal, we employed a competitive inhibitor of NOS -N G -nitro-L-arginine (L-NAME) -which was administered either acutely (prior to spinal cord injury) or chronically (for 4 weeks before the injury procedure) to Wistar rats. Acute pretreatment with pentolinium (ganglionic blocker) or atropine (competitive antagonist of muscarinic receptors) was used to prevent sympathetic nerve discharge or baroreflex-induced HR reduction, respectively.
MATERIALS AND METHODS

Animals
We used 94 male Wistar rats (Velaz, Prague, Czech Republic) with body weights between 300-330 g. This study was performed in accordance with the European Communities Council Directive of 24th of November 1986 (86/609/EEC) regarding the use of animals in research and was approved by the Ethical Committee of the Institute of Experimental Medicine ASCR, Prague, Czech Republic. All efforts have been made to decrease the number of animals used in the study.
Design of the study
Animals were randomly divided into 14 experimental groups (Table 1) according to the following criteria: (1) presence of spinal cord injury, (2) dose of isoflurane anesthesia, (3) acute or chronic L-NAME administration, and (4) pentolinium or (5) atropine administration.
Animals were anesthetized with either 1.5% or 3% isoflurane in air (flow 300 ml/min), and an arterial catheter for the monitoring of BP and HR as well as a venous catheter for the administration of L-NAME, pentolinium or atropine were inserted into the common carotid artery and internal jugular vein, respectively, and exteriorized in the interscapular region. The animal was put in a prone position, and the balloon compression of spinal cord was performed. Rats were sacrificed 10 min after lesioning (i.e. after balloon deflation), and the grade of neurogenic pulmonary edema was independently evaluated using macroscopic visual examination of subpleural bleeding and the p-index (lung weight/body weight x 100).
Controls were healthy non-injured animals, sacrificed immediately after the induction of anesthesia. The possible role of isoflurane in inducing neurogenic pulmonary edema per se was excluded in our previous study (18) .
Balloon compression spinal cord lesion
To induce a spinal cord injury, we used the model of an epidural balloon compression lesion (25) , as described previously (18) . Briefly, under aseptic conditions, a 2 cm median skin incision at the Th10-L1 level was made. The dorsal muscles were shifted laterally, and the Th10 and Th11 spinous processes were removed. A hole was drilled into the Th10 lamina with a dental drill. Then, a 2F French Fogarthy catheter (Baxter Healthcare Corporation, Irvine, CA, USA), which was filled with distilled water and connected to a 50-µl Hamilton syringe, was inserted into the dorsal epidural space 10 mm rostrally, to reach the Th8-Th9 spinal level. Using a micromanipulator, the balloon was rapidly inflated to 15 μl, and the inflated balloon was left in place for 5 min. Subsequently, the balloon was deflated and removed.
The immediate inflation of the balloon in the epidural space of the thoracic spinal channel with 15 μl water under 1.5% isoflurane anesthesia reliably and reproducibly produces severe neurogenic pulmonary edema (18, 19) . On the other hand, animals that undergo the same procedure under 3% isoflurane anesthesia do not develop neurogenic pulmonary edema (18, 19) . In the present experiments we therefore used these two contrasting models, in which the role of NO as well as the importance of early bradycardia were studied.
Evaluation of neurogenic pulmonary edema
The lungs were immediately removed from sacrificed animal and weighed by an independent investigator. To estimate the liquid accumulation in the lungs, both lungs were weighed, and the relative pulmonary weight was calculated as the pulmonary index (lung weight/body weight x 100), which has been previously considered to be very sensitive to the degree of pulmonary edema (9, 10, 14, 15, 18) . In all cases, a mild hematoma, maximally 1 mm in diameter, was found in the hilus area due to the manipulation of the pulmonary vessels during lung removal (not taken into further account). The level of pulmonary subpleural bleeding was evaluated macroscopically as "Absent" (no bleeding on the lung surface), "Grade I" (small bleeding areas, occupying not more than 10% of the lung surface), "Grade II"
(medium-sized bleeding areas, occupying 11-50% of the lung surface) and "Grade III"
(massive bleeding areas, occupying more than 50% of the lung surface), as described previously (18, 19) . Each lung was evaluated separately. In our previous experiments, we documented that the pulmonary index and the extent of subpleural bleeding clearly correspond to the histological picture of the severity of lung edema (18, 19, 22) , thus the histology was not performed in the current experiments.
Measurement of BP and HR changes
Mean arterial pressure (MAP, mm Hg) and HR (bpm) were monitored for 5 min before the procedure, throughout the entire procedure and for 15 min after the balloon compression of the spinal cord in Groups 1-13 of this study using a PowerLab system (ADInstruments, Colorado Springs, USA). The competitive inhibitor of nitric oxide synthase L-NAME (Sigma, St. Louis) was administered either acutely before the spinal cord injury (30 mg/kg i.v., reported as "acute") or for 4 weeks before the injury procedure (40 mg/kg/day in the drinking fluid, reported as "chronic"). To eliminate the influence of the sympathetic nervous system, we administered the ganglionic blocker pentolinium (5 mg/kg i.v., Sigma) 2 min before balloon inflation. To limit the baroreflex-induced HR decrease, atropine (4 mg/kg i.v., Sigma) was given 2 min before spinal cord injury. The hemodynamic values were obtained at the following time points: 1) the baseline value before the onset of surgery, 2) the maximum value after L-NAME administration, 3) the maximum value after balloon insertion, 4) the 8 minimum value after pentolinium or atropine administration, 5) the maximum value after balloon inflation, 6) the value 2 min after balloon inflation, and 7) the value after 10 min of recovery. The BP rise and HR changes elicited by spinal cord compression were evaluated by subtracting the values found after balloon insertion (groups 1-3 and 10-12) from the peak values seen after balloon inflation. In groups subjected to pharmacological interventions (groups 4-6 and 7-9) we subtracted the values found after pentolinium or atropine administration from the corresponding peak values.
Statistical analysis
The pulmonary index, MAP and HR are reported as mean values ± S.E.M. One-way ANOVA with a post hoc LSD (least significant difference) test was used for comparison among the individual groups.
RESULTS
Spinal cord injury under different degrees of isoflurane anesthesia
The rapid inflation of the balloon in the spinal channel of animals anesthetized with 1.5% isoflurane anesthesia caused a considerable BP elevation, HR decrease and severe neurogenic pulmonary edema in all cases. The pulmonary index and the extent of subpleural bleeding (Table 1) as well as the BP rise and HR decrease ( Table 2 , Fig. 1A ) corresponded to the values observed previously for this model of severe neurogenic pulmonary edema (19) .
Conversely, the same procedure performed under 3% isoflurane anesthesia did not promote neurogenic pulmonary edema.
Effect of L-NAME administration in rats anesthetized with 1.5% isoflurane (Groups 1-3)
Acute L-NAME injection before the spinal cord injury was associated with 83% mortality following spinal cord compression. All of the animals died within 10 min after balloon inflation due to a rapid development of neurogenic pulmonary edema. A few minutes before death, their breathing frequency started to increase slowly, and they began to develop a socalled "death rattle". Subsequently, their ventilation stopped, and after several seconds, large amount of gaseous blood came out of their nostrils, followed by the cessation of their heart beat. The amount of gaseous blood was substantially larger than that observed in our 1.5% isoflurane model of severe neurogenic pulmonary edema. The pulmonary index was significantly increased when compared to the 1.5% isoflurane model (Group 1) ( Table 1) .
Acute L-NAME administration caused a moderate increase in BP (20 mm Hg) accompanied by about a 10% decrease in HR in animals anesthetized with 1.5% isoflurane. In these rats (Group 2) balloon insertion into the epidural space already caused a small BP elevation, which was seen not only in this group but also in groups 5 and 8 (prior to pentolinium or atropine injection). Acute L-NAME administration attenuated the BP rise but augmented the bradycardia accompanying the BP rise occurring shortly after spinal cord compression in rats anesthetized with 1.5% isoflurane (Group 2 vs. Group 1) (Fig. 1B, Fig. 2 ).
Chronic L-NAME administration for 4 weeks caused a moderate elevation of basal BP similar to that seen after acute L-NAME injection, but it affected the development of neurogenic pulmonary edema less than did acute L-NAME administration. Only 33 % of the chronically L-NAME-treated animals died due to NPE, and their p-index was significantly lower compared to those in rats subjected to acute L-NAME treatment (Group 3 vs. Group 2).
However, the p-index was not significantly increased when compared to our 1.5% isoflurane model (Group 1). BP elevation and HR decrease after spinal cord injury were comparable to that seen in the acutely L-NAME-treated rats (Group 2) ( Table 2 ). Nevertheless, the marked HR decrease accompanying BP elevation also promoted the development of severe neurogenic pulmonary edema in chronically L-NAME-treated spinal cord-injured rats (Group 3).
Effect of preventive pentolinium administration in rats anesthetized with 1.5% isoflurane (Groups 4-6)
Ganglionic blockade by pentolinium prevented the BP rise, bradycardia and the development of neurogenic pulmonary edema in rats anesthetized with 1.5% isoflurane (Group 4) as observed previously (18) . Importantly, pretreatment with pentolinium also prevented NPE development and bradycardia in rats treated acutely or chronically with L-NAME (Groups 5 and 6) ( Tables 1 and 2 ). In fact, in pentolinium-pretreated rats the spinal cord compression usually elicited a HR acceleration instead of the typical bradycardia (Fig. 2) . These results show the importance of a HR decrease under the conditions of a BP increase for the development of neurogenic pulmonary edema.
Effect of preventive atropine injection in rats anesthetized with 1.5% isoflurane (Groups 7-9)
The administration of atropine 2 min before balloon inflation caused a significant BP decrease prior to spinal cord injury without affecting the HR. This pharmacological intervention completely prevented the development of neurogenic pulmonary edema in untreated animals (Group 7), whereas it only attenuated NPE development in rats acutely treated with L-NAME (Group 8) in which both mortality and the p-index were significantly reduced compared to Group 2 (Table 1) . On the other hand, atropine pretreatment also prevented NPE development in rats chronically treated with L-NAME (Group 9). Importantly, in all these groups atropine administration prevented the HR decrease, but not the BP elevation, occurring early after balloon inflation ( Table 2 ). The BP rise elicited by spinal cord compression in atropinepretreated rats tended to be higher than in non-pretreated rats (Group 7-9 vs Groups 1-3) (Fig.   2 , Table 2 ). After atropine pretreatment, spinal cord compression did not elicit the characteristic bradycardia, but rather a borderline HR acceleration (Fig. 1D) , which tended to be smaller in atropine-pretreated animals (Groups 7-9) than in rats pretreated with pentolinium (Groups 4-6) (Fig. 2) .
Effect of L-NAME administration in rats anesthetized with 3% isoflurane (Groups 10-12)
Neither acute nor chronic administration of L-NAME promoted neurogenic pulmonary edema in animals anesthetized with 3% isoflurane. In addition, the values of the pulmonary index in rats treated with L-NAME tended to be lower than those in animals without L-NAME administration (Groups 11 and 12 vs Group 10) ( Table 1) . Although pulmonary edema did not develop in any animal from the 3% isoflurane groups (irrespective of L-NAME treatment), the magnitude of the BP increase after balloon inflation seen in particular 3% isoflurane groups was comparable to the changes seen in the corresponding 1.5% isoflurane groups. Nevertheless, HR did not decrease after balloon compression of the spinal cord in any of the 3% isoflurane groups (Table 2 , Fig. 1C ), indicating that baroreflex-induced bradycardia during the hypertensive reaction might be an important mechanism for the development of NPE.
Finally, we demonstrated that the development of neurogenic pulmonary edema can not be influenced by the therapeutic administration of atropine (4 mg/kg i.v.) two minutes after balloon compression of the spinal cord (Group 13). The delayed atropine injection had no positive effect on NPE development in rats with spinal cord injury (p-index 0.78±0.04, n=8).
In this group there was a similar BP rise (+51±4 mm Hg) and HR reduction (-138±29 bpm) after the balloon compression lesion as in untreated rats subjected to spinal cord compression in 1.5 % isoflurane anesthesia.
DISCUSSION
The present study confirmed our original findings (18) that balloon compression of the thoracic spinal cord results in NPE development in rats anesthetized with 1.5 % isoflurane but not in those anesthetized with 3 % isoflurane. The inflation of a balloon to 15 μl in the spinal channel caused a considerable BP increase in both groups, but this BP rise was accompanied by a HR reduction only in rats anesthetized with 1.5 % isoflurane (Fig. 2) . The proposed importance of the sympathetic nervous system (SNS) for the development of neurogenic pulmonary edema (12, 16) raised the question of whether the elimination of nitric oxide would enhance the deleterious effects of SNS activation on NPE development because NO is known to attenuate peripheral sympathetic vasoconstriction (26) and to inhibit central sympathetic tone (13) .
Acute NOS inhibition worsened NPE development in the 1.5 % isoflurane model (Group 2 vs. Group 1), whereas no significant effect of NOS inhibition on NPE development was observed in the 3 % isoflurane model (Groups 11 and 12 vs. Group 10). A similar deleterious effect of L-NAME administration on the severity and occurrence of neurogenic pulmonary edema was reported by Hamdy et al. (5), whereas increased NO production reduced the severity of NPE in a similar model (8) . The worsening of NPE development in NO-deficient rats anesthetized with 1.5 % isoflurane was not associated with a greater BP rise, but there was a clear-cut tendency towards a more pronounced HR reduction after balloon inflation (Fig. 2) . The mechanism underlying the adverse effects of NO deficiency on NPE development is probably based upon the lack of vasodilator NO action counteracting a part of the sympathetic vasoconstriction so that a more profound baroreflex-induced bradycardia might occur (13, 26, 27) . The most striking difference between NO-deficient rats subjected to 1.5 % or 3 % isoflurane anesthesia was the presence of baroreflex-induced bradycardia in the former animals, whereas no significant HR changes were observed after balloon compression of the spinal cord in rats anesthetized with 3 % isoflurane (Fig. 2) . This is in accordance with earlier findings that higher isoflurane concentrations decrease the baroreflex gain in the control of HR and sympathetic nerve activity (2, 11, 17) .
The above findings suggest that the mechanism(s) of NPE development might involve sympathetic venoconstriction leading to blood mobilization from the systemic circulation into the pulmonary vessels. The concomitant activation of the arterial baroreflex, which is absent in rats anesthetized with 3% isoflurane, causes such a decrease in HR that it prevents effective blood pumping into the systemic circulation. Bradycardia has been recognized as an important factor contributing to NPE development in animals with intracranial hypertension (for review see ref. 12). Nevertheless, bradycardia occurring after intracranial hypertension appears to be initiated by the respective centers in the medulla oblongata rather than by peripheral baroreceptor feedback (3) . To test the role of bradycardia and its mechanism in our NPE model, we have successfully employed two different interventions to prevent a baroreflexinduced HR reduction following spinal cord compression. First, a ganglionic blockerpentolinium -was used to prevent a sympathetic discharge leading to a BP increase and the consequent activation of the arterial baroreflex.
Pentolinium pretreatment indeed abolished the BP rise and bradycardia in both rats with preserved NO synthesis (Group 4) and also chronically NO-deficient rats (Group 6). On the other hand, a quite interesting response to spinal cord compression was found in pentoliniumpretreated rats subjected to acute NOS inhibition (Group 5) (Fig. 2, Table 2 ). The mechanism of this surprising pressor response in acutely NO-deficient rats subjected to ganglionic blockade is not clear, but we can speculate about the involvement of other pressor agents (angiotensin II, endothelin-1, vasopressin) acting on the resistance vasculature in the absence of sympathetic vasoconstriction.
The second intervention used in our study was atropine pretreatment aimed at interrupting the cholinergic mechanisms mediating the baroreflex-induced bradycardia elicited after spinal cord compression. Preventive atropine administration not only abolished this bradycardia in both untreated and NO-deficient rats (Groups 7-9), but also converted it into moderate tachycardia in both groups. This atropine pretreatment completely prevented the occurrence of NPE in both untreated and chronically NO-deficient animals anesthetized with 1.5 % isoflurane (Groups 7 and 9) and significantly attenuated NPE development in acutely NOdeficient rats subjected to the same anesthesia (Group 8). Since therapeutic administration of atropine 2 min after balloon inflation (Group 13) had no beneficial effect on NPE development, it is evident that an early bradycardic response after spinal cord compression is decisive for NPE pathogenesis.
PERSPECTIVES AND SIGNIFICANCE
Our data indicate that the development of neurogenic pulmonary edema in rats subjected to moderate anesthesia (1.5% isoflurane) is dependent upon a marked decrease of HR under the conditions of high BP elicited by the activation of the sympathetic nervous system. This vicious circle can be interrupted either by ganglionic blockade (attenuating the sympathetic discharge) or by the blockade of cholinergic muscarinic receptors (eliminating the HR reduction). The above hemodynamic alterations are especially pronounced in rats subjected to acute NO synthase inhibition. Nitric oxide has a partial protective effect on NPE development because it attenuates sympathetic vasoconstriction, BP rise and subsequent baroreflex-induced bradycardia following spinal cord injury. Further research should elucidate the therapeutic potential of atropine and/or other parasympatholytic agents in other (less severe or slowly developing) models of neurogenic pulmonary edema. Significant differences (p<0.05): * vs. respective group anesthetized with 3 % isoflurane, # effect of acute L-NAME vs. respective group without L-NAME, • effect of pentolinium vs.
respective group anesthetized with 1.5 % isoflurane, ○ effect of atropine vs. respective group Table 1 . Lung impairment after spinal cord injury in individual experimental groups (anesthetized with 1.5% or 3% isoflurane) subjected to either acute or chronic L-NAME treatment with or without pentolinium or atropine pretreatment. , # significantly higher from the 1.5% model (Group 1), $ from the 1.5% model acutely treated with L-NAME (Group 2), + from the 1.5% model chronically treated with L-NAME (Group 3). The occurrence of death is shown as the total number of deaths in each group and as the percentage of all animals in the group. Control animals are animals without spinal cord injury, sacrificed immediately after the onset of anesthesia. N -number of rats, 2N -number of lungs. Table 2 . Baseline mean arterial pressure and heart rate values as well as the values found after particular surgical procedures in rats anesthetized with 1.5% or 3% isoflurane and subjected to acute or chronic L-NAME treatment as well as to preventive pentolinium or atropine treatment. A -influence of acute L-NAME administration vs corresponding control (groups 2 vs 1; 5 vs 4; 8 vs 7; 11 vs 10) B -influence of chronic L-NAME administration vs corresponding control (groups 3 vs 1; 6 vs 4; 9 vs 7; 12 vs 10) C -influence of pentolinium administration vs corresponding control (groups 4 vs 1; 5 vs 2; 6 vs 3) D -influence of atropine administration vs corresponding control (groups 7 vs 1; 8 vs 2; 9 vs 3) E -the difference between 1.5% and 3% isoflurane anesthesia (groups 10 vs 1; 11 vs 2; 12 vs 3) For legend see the first part of the Table 2 
